During the past decade, Puget Sound Oncology Consortium conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 3 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Puget Sound Oncology Consortium" #1 sponsor was "SWOG Cancer Research Network" with 10 trials, followed by "NSABP Foundation Inc" with 8 trials sponsored, "Alliance for Clinical Trials in Oncology" with 2 trials sponsored, "Eastern Cooperative Oncology Group" with 1 trials sponsored and "Memorial Sloan Kettering Cancer Center" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Puget Sound Oncology Consortium" #1 collaborator was "National Cancer Institute (NCI)" with 22 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 2 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Puget Sound Oncology Consortium" are "Breast Cancer" (9 trials), "Colorectal Cancer" (3 trials), "Extragonadal Germ Cell Tumor" (2 trials), "Lymphoma" (2 trials) and "Testicular Germ Cell Tumor" (2 trials). Many other conditions were trialed in "Puget Sound Oncology Consortium" in a lesser frequency.

Most popular intervention types in "Puget Sound Oncology Consortium" are "Drug" (21 trials), "Procedure" (7 trials), "Biological" (6 trials), "Radiation" (5 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "cyclophosphamide" (9 trials), "etoposide" (5 trials), "radiation therapy" (5 trials), "carboplatin" (4 trials) and "conventional surgery" (4 trials). Other intervention names were less common.

The vast majority of trials in "Puget Sound Oncology Consortium" are 11 trials for "Female" genders, 10 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Puget Sound Oncology Consortium". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Puget Sound Oncology Consortium, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Puget Sound Oncology Consortium, 1 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".